Montgomery Blake K, Cahan Eli M, Frick Steve
Orthopaedic Surgery, Stanford University, Palo Alto, USA.
Orthopaedics, Stanford University, Palo Alto, USA.
Cureus. 2019 Dec 23;11(12):e6452. doi: 10.7759/cureus.6452.
Background Multiple hereditary exostoses (MHE) is a rare disease characterized by multiple osteochondromas. Osteochondromas growing into the spinal canal can produce devastating consequences, including permanent neurologic deficits and even death. Routine screening of the entire spinal canal with magnetic resonance imaging (MRI) is a controversial topic lacking a clear consensus or recommendation to guide decision-making. This study presents a case of an intracanal osteochondroma at C1 identified by routine screening and a survey describing current practices of MHE experts. Methods MHE experts were surveyed. Survey questions addressed multiple aspects of care, including the type of practice center, the volume of patients with MHE, and current screening practices. Results A total of 104 experts were contacted, with a total of 26 experts participating in the survey and 23 completing the entire survey. Seventy-two percent of respondents do not perform a routine MRI screen of the spine. For experts that routinely screen, screening is performed across a wide/variable age range (4-18 years). Conclusion Screening protocols for MHE patients to identify osteochondromas within the spinal canal has struggled to reach consensus due to the rarity of the disease. Recent literature provides conflicting advice for patients without neurological symptoms. Our study demonstrates that even experts who are leading the field demonstrate wide practice variability. Most respondents do not routinely perform screening spinal MRI. Due to the wide variability, a national guideline is needed to help guide physician and parental decision-making for patients with MHE. Our case illustrates the potential benefit of identifying an osteochondroma within the spinal canal at a location where further growth could have devastating neurological sequelae.
背景 多发性遗传性骨软骨瘤(MHE)是一种以多发性骨软骨瘤为特征的罕见疾病。生长进入椎管的骨软骨瘤可产生严重后果,包括永久性神经功能缺损甚至死亡。使用磁共振成像(MRI)对整个椎管进行常规筛查是一个存在争议的话题,缺乏明确的共识或建议来指导决策。本研究报告了一例通过常规筛查发现的C1椎管内骨软骨瘤病例,并进行了一项调查以描述MHE专家的当前做法。方法 对MHE专家进行了调查。调查问题涉及护理的多个方面,包括执业中心类型、MHE患者数量以及当前的筛查做法。结果 共联系了104位专家,共有26位专家参与调查,23位专家完成了全部调查。72%的受访者不进行脊柱的常规MRI筛查。对于常规进行筛查的专家,筛查在较宽/可变的年龄范围(4 - 18岁)内进行。结论 由于该疾病罕见,MHE患者识别椎管内骨软骨瘤的筛查方案难以达成共识。近期文献对于无神经症状的患者提供了相互矛盾的建议。我们的研究表明,即使是该领域的领军专家,其做法也存在很大差异。大多数受访者不常规进行脊柱MRI筛查。由于差异很大,需要一个国家指南来帮助指导医生和家长对MHE患者的决策。我们的病例说明了在一个进一步生长可能产生严重神经后遗症的位置识别椎管内骨软骨瘤的潜在益处。